{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-255981","form_type":"8-K","ticker":"GRDN","cik":"0001802255","company_name":"Guardian Pharmacy Services, Inc.","filed_at":"2024-11-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.687532+00:00","generated_at":"2026-05-30T02:06:53.147476+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Guardian Pharmacy Q3 revenue $314M (+20% YoY); Adj. EBITDA $23M (+20%); guides FY24","bullets":["Revenue of $314.4M (+20% YoY) driven by organic growth and Heartland Pharmacy acquisition.","Net loss of $105.8M due to $122.4M share-based comp from IPO; Adj. EBITDA of $23.0M (+20% YoY).","Resident count of 180,000 at quarter-end, up 12% YoY.","FY 2024 guidance: revenue $1.205B-$1.215B, Adjusted EBITDA $86.5M-$87.0M.","Completed a small acquisition in Q3, entering a new market with a strong operating team."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-255981","json":"https://secwatch.observer/filing/0001193125-24-255981.json","markdown":"https://secwatch.observer/filing/0001193125-24-255981.md","text":"https://secwatch.observer/filing/0001193125-24-255981.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1802255/000119312524255981/0001193125-24-255981-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1802255/000119312524255981/d895150d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T02:06:53.147476+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}